TotalMarketCap

United Therapeutics

UTHRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$24.139 B

$566.79 -6.85%

Close of 6 Nov 2026

As of 6 Nov 2026, United Therapeutics (UTHR) has a market capitalization of $24.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.18B

#881 by revenue

Earnings

$1.33B

#310 by earnings

Shares outstanding

42,588,726

Latest filing cover page

P/E ratio

18.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #20Genmab A/SGMAB$33.0B
  2. #21Roivant SciencesROIV$26.5B
  3. #22United TherapeuticsUTHR$24.1B
  4. #23InsmedINSM$23.9B
  5. #24ViatrisVTRS$21.8B

What if United Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$663,012.88

Per share 1,170× higher

Bitcoin $1.53T

$35,874.47

Per share 63.3× higher

Apple $5.02T

$117,772.54

Per share 208× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for United Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.